Structured evidence table for Peppermint Nausea Healthy Adults Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Peppermint Nausea Healthy Adults Meta-Analysis | Abdominal pain must be associated with two or more of the following: defecation, change in stool frequency, or change in stool form (Rome [Foundation] IV criteria;). | 4 | Ladewski Amy M. (2026) | Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations |
| Peppermint Nausea Healthy Adults Meta-Analysis | The emphasis that NPs and PAs place on holistic, patient-centered care provides increased opportunities for education and counseling, and patients with disorders of gut–brain interaction, such as IBS, would benefit from a collaborative treatment approach that validates their experiences and addresses their most bothersome symptoms (;;). | 4 | Ladewski Amy M. (2026) | Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations |
| Peppermint Nausea Healthy Adults Meta-Analysis | He reported no evidence of rectal bleeding or unintentional weight loss and had no known family history of colorectal cancer, inflammatory bowel disease (IBD), or other GI conditions. | 4 | Ladewski Amy M. (2026) | Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations |
| Peppermint Nausea Healthy Adults Meta-Analysis | This condition is characterized by recurrent abdominal pain occurring at least 1 day per week, on average, during the previous 3 months, with symptom onset at least 6 months before diagnosis. | 4 | Ladewski Amy M. (2026) | Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations |
| Peppermint Nausea Healthy Adults Meta-Analysis | Tables 1 2 In the current literature, different results were obtained in meta-analyzes related to the efficacy of antispasmodics, and we found that the studies evaluated in the meta-analyzes were different, and the results were variable(and) because each meta-analysis covers different studies with different inclusion and exclusion criteria. | 4 | Bor Serhat (2025) | Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome |
| Peppermint Nausea Healthy Adults Meta-Analysis | As a result of evaluating the studies on the efficacy of the drugs, the quality of evidence for each drug was determined, and the drugs were subsequently classified into four categories. | 4 | Bor Serhat (2025) | Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome |
| Peppermint Nausea Healthy Adults Meta-Analysis | While Grade A shows high quality evidence, Grade D has been evaluated as very low quality of evidence (). | 4 | Bor Serhat (2025) | Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome |
| Peppermint Nausea Healthy Adults Meta-Analysis | Antispasmodics constitute the drug group with different mechanisms of action, some known like direct relaxation of smooth muscles (mebeverine, peppermint oil (PO)), blocking cholinergic receptors (hyoscine butyl bromide (HBB), hyoscyamine, pirenzepine), blocking calcium (Ca2+) channels (alverine citrate (AC), pinaverium bromide (PB), otilonium bromide (OB) and some unknown or mixed action mechanisms. | 4 | Bor Serhat (2025) | Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome |
Source documents